For example, ADAR1’s role as a prognostic biomarker in gastric cancer [109] versus prostate cancer [110] may be caused by differences in immune infiltration or tumor-intrinsic pathways (e.g. IFN-γ signaling vs. androgen receptor activity) [111]. This evidence concerns the gene ADAR and neoplasm.